During the past decade, Nuovo Ospedale Civile S. Agostino-Estense conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nuovo Ospedale Civile S. Agostino-Estense" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Janssen Sciences Ireland UC" with 2 trials sponsored, "Alector Inc." with 1 trials sponsored, "Consorzio Futuro in Ricerca" with 1 trials sponsored and "CymaBay Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nuovo Ospedale Civile S. Agostino-Estense" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nuovo Ospedale Civile S. Agostino-Estense" are "Hepatitis B, Chronic" (3 trials), "Atrial Fibrillation" (2 trials), "Stroke" (2 trials), "Acute Pancreatitis" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Nuovo Ospedale Civile S. Agostino-Estense" in a lesser frequency.

Most popular intervention types in "Nuovo Ospedale Civile S. Agostino-Estense" are "Drug" (7 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "JNJ-56136379" (2 trials), "JNJ-73763989" (2 trials), "Placebo" (2 trials), "Placebo for JNJ-56136379" (2 trials) and "Placebo for JNJ-73763989" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nuovo Ospedale Civile S. Agostino-Estense" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Nuovo Ospedale Civile S. Agostino-Estense". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Nuovo Ospedale Civile S. Agostino-Estense, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nuovo Ospedale Civile S. Agostino-Estense, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".